Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene

Lancet

Volumn 347, Issue 9011, 1996, Pages 1294-1296

  Williams, Julie ^a   Spurlock, Gillian ^a   McGuffin, Peter ^a   Mallet, Jacques ^b   Nöthen, Markus M ^c   Gill, Michael ^d   Aschauer, Harald ^e   Nylander, Per Olof ^f   Macciardi, Fabio ^g   Owen, Michael J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY OF BONN   (Germany)

^d ST JAMES S HOSPITAL   (Ireland)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f UMEÅ UNIVERSITY   (Sweden)

^g UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RESTRICTION ENDONUCLEASE; SEROTONIN 2A RECEPTOR;

ARTICLE; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION MAPPING; SCHIZOIDISM; SCHIZOPHRENIA;

EID: 0029873266     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90939-3     Document Type: Article

References (17)

1. McGuffin P, Owen MJ, Farmer AE. The genetic basis of schizophrenia. Lancet 1995; 346: 678-82.
2. Plomin R. The role of inheritance in behaviour. Science 1990; 248: 183-88.
3. Owen MJ, McGuffin P. Association and linkage complementary strategies for complex disorders. J Med Genet 1993; 30: 638-39.
4. Nöthen MM, Fimmers R, Propping P. Association versus linkage studies in psychosis genetics. J Med Genet 1993; 30: 634-37.
5. Williams J, Owen MJ, Spurlock G, McGuffin P. Searching for susceptibility genes for schizophrenia: the European Multicentre Association Study. New Trends Exp Clin Psychiatry 1995; 11: 7-12.
6. Warren JT Jr, Peacock ML, Rodriguez LC, Fink JK. An Msp1 polymorphism in the human serotonin receptor gene (HTR2): detection by DGGE and FLP analysis. Hum Mol Genet 1993; 2: 338.
7. Gaddum JH. Drugs antagonistic to 5-hydroxytryptamine. In: Wolstenholme GW, ed. Ciba foundation symposium on hypertension. Boston: Little Brown and Company, 1954: 75-77.
8. Leysen JE, Janssen PM, Megen AHP, Schotte A. Risperidone: a novel antipsychotic with a balanced serotonin-dopamine antagonism, receptor occupancy profile and pharmacologic activity. J Clin Psychiatry 1994; 55 (suppl): 5-12.
9. 2a receptor genes. Lancet 1995; 346: 281-82.
10. Inayama Y, Yoneda H, Ishida T, et al. An association between schizophrenia and a serotonin receptor DNA marker (5HTR2). Neuropsychopharmacology 1994; 10: 56s.
11. McGuffin P, Farmer AE, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991; 48: 764-70.
12. Williams J, Farmer AE, Ackenheil M, et al. A multicentre inter-rater reliability study using the OPCRIT computerised diagnostic system. Psychol Med 1996 (in press).
13. Woolf B. On estimating the relation between blood groups and disease. Ann Hum Genet 1955; 19: 251-53.
14. Smith CAD, Smith G, Wolf CR. Genetic polymorphisms in zenobiotic metabolism. Eur J Cancer 1994; 30a (13): 1921-35.
15. 2a receptor and response to clozapine. Lancet 1995; 346: 909.
16. 2a receptor and response to clozapine. Lancet 1995; 346: 908-09.
17. 2a) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet 1996; 97: 614-19.